Unique ID issued by UMIN | UMIN000015757 |
---|---|
Receipt number | R000017783 |
Scientific Title | Research on a Quantitative Assessment of Radiation-Induced Skin Symptoms |
Date of disclosure of the study information | 2014/11/26 |
Last modified on | 2020/06/12 18:09:49 |
Research on a Quantitative Assessment of Radiation-Induced Skin Symptoms
Quantitative Assessment of Radiation-Induced Skin Symptoms
Research on a Quantitative Assessment of Radiation-Induced Skin Symptoms
Quantitative Assessment of Radiation-Induced Skin Symptoms
Japan |
Breast cancer
Radiology | Adult |
Malignancy
NO
The purposes of this study are to assess multilateral changes of radiation-induced skin symptoms quantitatively and find out relations with the exposure dose. The study also uses a qualitative grading evaluation and QOL questionnaires and examines the effectiveness of the assessments.
Others
To assess successive changes in skin symptoms.
Period: Before radiation therapy, during radiation therapy (once in a week), after radiation therapy (2 and 6 weeks, 3 and 6 months, and 1 year post treatment)
<Assessment by devices>
Erythema & melanin index
Period: Before radiation therapy, during radiation therapy (once in a week), after radiation therapy (2 and 6 weeks, 3 and 6 months, and 1 year post treatment)
<Assessment by devices>
1) Transepidermal water loss
2) Capacitance (stratum corneum-epidermal water)
3) Skin temperature
<Visual assessment>
NCI-CTC (ver.4.0 Japanese version JCOG)
<Self-completed questionnaires>
Skindex 29 (QOL regarding skin symptoms)
Observational
20 | years-old | <= |
69 | years-old | >= |
Female
1) Patients with breast cancer who are treated with whole-breast radiation after breast-conserving surgery.
2) PS is from 0 to 1.
3) Patients who agreed to participate in this study.
1) Patients who should be treated with a boost radiation.
2) Patients who are treated with pharmacotherapy except for hormone therapy during radiation therapy.
3) Patients who are unable to respond to self-completed questionnaires.
4) Physician decides it is inappropriate for the patient to participate in this study.
5) Patients who are going to stop radiation therapy for a long time (e.g., at the end of and the beginning of a year).
60
1st name | Hiroshi |
Middle name | |
Last name | Sekine |
The Jikei University School of Medicine
Department of Radiology
201-8601
4-11-1 Izumi-Honcyo, Komae, Tokyo 201-8601, Japan
03-3480-1151
h-sekine@jikei.ac.jp
1st name | Nozawa |
Middle name | |
Last name | Keiko |
National Cancer Center Hospital
Appearance Support Center
104-0045
5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045
03-3547-5201(3015)
knozawa@ncc.go.jp
National Cancer Center Hospital, Appearance Support Center
Health and Labor Sciences Research Grants 2014
Japanese Governmental office
The Jikei University
Mie University
Tohoku University
National Cancer Center Institutional Review Board
5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045
03-3542-2511
NCC_IRBoffice@ml.res.ncc.go.jp
NO
国立がん研究センター中央病院(東京都)、東京慈恵会医科大学病院(東京都)
三重大学病院(三重県)、東北大学病院(宮城県)
2014 | Year | 11 | Month | 26 | Day |
Breast Cancer On line: 03 May 2020 https://doi.org/10.1007/s12282-020-01082-3
Published
Breast Cancer On line: 03 May 2020 https://doi.org/10.1007/s12282-020-01082-3
43
Finally, 40 patients were followed until 1 year after irradiation.
The order of symptom manifestation for the qualitative evaluation was skin erythema, dryness, and pigmentation. Quantitative measurements revealed the effects of irradiation earlier than did qualitative indices. Although the grades of skin erythema and pigmentation were correlated with the quantitative measurements, no significant correlation was observed between the skin dryness grade and skin barrier function.
2020 | Year | 06 | Month | 12 | Day |
Female patients with newly diagnosed unilateral breast cancer were enrolled. All patients underwent BCS followed by whole-breast irradiation (WBI).
The exclusion criteria were an age >70 years; previous history of contralateral beast cancer; receipt of boost irradiation after WBI; receipt of chemotherapy before, simultaneously with, or after the completion of irradiation; connective tissue disease; and expected long-term interruption of radiation therapy.
Participants who received BCS were irradiated with tangential opposed fields with a dose of 50 Gy in 25 fractions. Qualitative and quantitative evaluation of radiation dermatitis were performed weekly during irradiation and periodically until 1 year of irradiation.
This study confirms whether the qualitative evaluation of radiation dermatitis, which is a side effect of radiotherapy, is reproducible between and within evaluators by comparing it with quantitative evaluation. The subject is a radiotherapy patient after breast-conserving surgery in which the method of radiotherapy is uniform. There were no adverse effects that interrupted the irradiation with this treatment.
Symptoms (erythema, pigmentation, and skin dryness) and biophysical parameters (erythema, pigmentation, barrier function, and skin temperature) of radiation dermatitis were measured weekly during radiation therapy and periodically until 1 year after irradiation.
Completed
2014 | Year | 11 | Month | 04 | Day |
2014 | Year | 10 | Month | 30 | Day |
2014 | Year | 12 | Month | 01 | Day |
2016 | Year | 03 | Month | 30 | Day |
This study evaluates radiation-induced skin symptoms and QOL quantitatively and qualitatively.
2014 | Year | 11 | Month | 26 | Day |
2020 | Year | 06 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017783
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |